Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Doofan Bur · Sankore

National Primary Health Care Development Agency

Doofan Bur

ORCID, self-asserted

ORCID 0000-0001-7625-7118

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

15

Citations

141

h-index

7

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

6

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

National Primary Health Care Development Agency14 works
National Biotechnology Development Agency8 works
National Institute for Pharmaceutical Research and Development1 works

Publications

15 works in the graph, newest first.

High-throughput design of defined microbial consortia for crop protection
2026Annals of BotanyJournalOpen accessSenior author13 citations10.1093/aob/mcag002
The Antiviral Nanotechnology Gap in COVID-19: Systematic Barriers to Pandemic-Scale Translation and Deployment
2026International journal of research and scientific innovationJournalOpen accessSenior author0 citations10.51244/ijrsi.2026.1315ph00064
Probiotics: An Emerging Tool against Pathogenic Bacteria
2026European Journal of BiologyJournalOpen accessFirst author0 citations10.26650/eurjbiol.2026.1781227
Harnessing Viruses Against Multidrug‐Resistant Bacteria: Exploring the Potential of Bacteriophage‐Based Drug Discovery
2026Advanced Gut & Microbiome ResearchJournalOpen accessFirst authorCorresponding0 citations10.1155/agm3/1271175

Advancing predictive modeling in computational chemistry through quantum chemistry, molecular mechanics, and machine learning

2025Discover Chemistry.JournalOpen accessSenior author12 citations10.1007/s44371-025-00363-0

Phyto-molecules show potentials to combat drug-resistance in bacterial cell membranes

2025Microbial PathogenesisJournal11 citations10.1016/j.micpath.2025.107723

Molecules of Therapeutic and Prophylactic Value in the Earthworm

2025Book Chapter1 citations10.1007/978-3-031-96212-7_5

Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies

2024The MicrobeJournalOpen access17 citations10.1016/j.microb.2024.100096

Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications

2024AnemiaJournalOpen access7 citations10.1155/2024/5431000

The Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Can Combat Cytokine Storm and Other COVID-19 Related Pathologies: A Review

2023International journal of medicinal mushroomsJournal9 citations10.1615/intjmedmushrooms.2023048109

Modulatory Effects of Mushrooms on the Inflammatory Signaling Pathways and Pro-inflammatory Mediators

2022Clinical Complementary Medicine and PharmacologyJournalOpen access46 citations10.1016/j.ccmp.2022.100037

Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach

2022PLoS neglected tropical diseasesJournalOpen access15 citations10.1371/journal.pntd.0009799

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever

2022Clinical and Experimental Vaccine ResearchJournalOpen access4 citations10.7774/cevr.2022.11.3.249

RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION

2022African Journal of Infectious DiseasesJournalOpen access4 citations10.21010/ajid.v16i2.9

In silico identification of the potential natural inhibitors of SARS-CoV-2 Guanine-N7 methyltransferase

2022RESEARCH RESULTS IN BIOMEDICINEJournalOpen access2 citations10.18413/2658-6533-2022-8-3-0-6